Manufacturers Life Insurance Company, The Immatics N.V. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Immatics N.V. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 164,766 shares of IMTX stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
164,766
Previous 150,769
9.28%
Holding current value
$1.2 Million
Previous $1.75 Million
7.31%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IMTX
# of Institutions
101Shares Held
75.8MCall Options Held
238KPut Options Held
727K-
Rtw Investments, LP New York, NY10MShares$72.7 Million1.82% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$70.4 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$58.8 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.38MShares$53.6 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$46.8 Million0.79% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $554M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...